| Metric | This Period | Prior Year Same Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥338.0B | ¥356.6B | -5.2% |
| Operating Income / Operating Profit | ¥53.4B | ¥49.0B | +9.1% |
| Ordinary Income | ¥55.7B | ¥52.1B | +6.9% |
| Net Income / Net Profit | ¥41.0B | ¥36.0B | +14.0% |
| ROE | 7.8% | 7.3% | - |
For the fiscal year ending March 2026, Revenue was ¥338.0B (¥-18.7B YoY -5.2%), Operating Income was ¥53.4B (¥+4.5B YoY +9.1%), Ordinary Income was ¥55.7B (¥+3.6B YoY +6.9%), and Net Income attributable to owners of the parent was ¥41.0B (¥+5.0B YoY +14.0%). The company achieved lower revenue and higher profits, with gross margin improving to 32.9% (up +2.4pt from 30.5% prior year) and operating margin rising substantially to 15.8% (up +2.1pt from 13.7%). Although sales in the core Functional Products segment declined, improvements in product mix and reductions in raw material costs supported margin expansion to 17.7% (up +2.6pt from 15.1% prior year). Environmental Hygiene Products also performed solidly with sales +2.8% and operating income +10.2%. A gain on sale of investment securities of ¥9.2B was recorded as an extraordinary gain, expanding profit before tax to ¥64.3B (up +19.4% from ¥53.8B prior year).
[Revenue] Revenue was ¥338.0B, down -5.2% YoY. By segment, Functional Products decreased to ¥265.2B (-7.4%), weighing on overall revenue, reflecting demand adjustments in core product groups such as cosmetic raw materials and wool grease derivatives. Conversely, Environmental Hygiene Products secured growth to ¥72.2B (+2.8%), supported by steady demand for commercial detergents and disinfectant products. Other segments (real estate leasing, etc.) contracted to ¥2.6B (-27.9%). FX effects were minimal; the revenue decline was mainly driven by volume and mix changes.
[Profitability] Operating Income was ¥53.4B, up +9.1% YoY. Gross profit was ¥111.3B (gross margin 32.9%), increasing ¥2.6B YoY and improving gross margin by +2.4pt. Stabilization of raw material markets and a shift to higher value-added product mix contributed. Selling, general and administrative expenses were ¥57.9B (SG&A ratio 17.1%), decreasing ¥1.9B YoY, demonstrating control of absolute SG&A amid lower sales. Non-operating income was ¥4.4B (primarily dividend income ¥3.5B), and non-operating expenses were ¥2.1B (including foreign exchange losses ¥0.4B), producing Ordinary Income of ¥55.7B (+6.9%). An extraordinary gain of ¥9.2B from sale of investment securities expanded profit before tax to ¥64.3B (+19.4%). After income taxes of ¥19.2B, Net Income attributable to owners of the parent was ¥41.0B (+14.0%), achieving higher profits despite lower revenue.
Functional Products: Revenue ¥265.2B (-7.4%), Operating Income ¥46.9B (+8.7%), with margin improving to 17.7% (up +2.6pt from 15.1%). A shift to higher value-added products such as cosmetic raw materials and phospholipids, together with reductions in raw material costs, drove margin expansion. As the core business, it accounted for 78.5% of company revenue and 87.8% of operating income, leading profitability. Environmental Hygiene Products: Revenue ¥72.2B (+2.8%), Operating Income ¥5.7B (+10.2%), margin improved to 7.9% (up +0.5pt from 7.4%), with steady demand for commercial detergents and medicated soap liquid delivering revenue and profit growth. Other segments (real estate leasing, etc.): Revenue ¥2.6B (-27.9%), Operating Income ¥0.8B (+30.1%), maintaining very high profitability at 31.4%.
[Profitability] Operating margin of 15.8% improved +2.1pt from 13.7% prior year, forming a three-year trend of rising operating margins. Net profit margin reached 12.1% (up +2.0pt from 10.1% prior year), the highest level in three years. ROE 7.8% was slightly down from 8.2% prior year, while Equity Ratio remained high at 80.1%, indicating profitability alongside high financial soundness; the three-year average ROE is a stable 8.0%. [Cash Quality] Operating Cash Flow (OCF) was ¥68.1B, 1.54x Net Income, with an accrual ratio of -3.6%, indicating high quality of earnings. OCF/EBITDA ratio was 0.99x, demonstrating strong cash conversion. [Investment Efficiency] Total Asset Turnover was 0.52x (prior year 0.60x), declining due to asset increases (investment securities +¥30.2B, tangible fixed assets +¥26.3B). Working capital efficiency lengthened with DSO 88 days, DIO 140 days, and CCC 176 days, warranting attention to working capital needs in any revenue re-acceleration phase. [Financial Soundness] Equity Ratio 80.1% (prior year 82.1%), D/E ratio 0.25x, Debt/EBITDA 0.16x—effectively near net-debt-free. Current ratio 342.9% and quick ratio 305.8% indicate very strong short-term liquidity. Cash and cash equivalents ¥132.0B versus short-term borrowings ¥3.0B, meaning minimal maturity mismatch risk. Investment securities ¥138.9B (prior year ¥108.7B) expanded due to valuation gains and partial sales, strengthening equity as latent assets.
Operating Cash Flow was ¥68.1B, up +66.7% YoY, and 1.54x Net Income ¥44.3B (including non-controlling interests), indicating high quality. Operating cash flow before working capital changes totaled ¥72.2B; increases in trade receivables -¥2.1B, decrease in inventories +¥1.2B, and increase in accounts payable +¥1.9B produced a net positive contribution. After absorbing corporate tax payments of ¥7.9B, the company generated ample cash. Investing Cash Flow was -¥22.3B, mainly driven by capital expenditures -¥28.2B (tangible fixed assets -¥28.2B, intangible fixed assets -¥0.3B). Proceeds from sale of investment securities ¥11.4B partially offset this, limiting net investment outflow. Construction in progress rose materially from ¥5.5B to ¥33.6B, indicating preparations for large-scale investments. Free Cash Flow was ¥45.9B, covering dividends ¥18.5B by 2.48x, and the company executed share buybacks of ¥20.6B. Financing Cash Flow was -¥40.0B, with dividend payments -¥18.5B, share buybacks -¥20.6B, and long-term borrowings raised +¥8.0B, resulting in net outflow. Cash and cash equivalents increased by ¥7.0B to ¥133.4B (prior year ¥126.4B), maintaining abundant liquidity.
Ordinary Income ¥55.7B derives from Operating Income ¥53.4B plus non-operating income ¥4.4B and minus non-operating expenses ¥2.1B; non-operating income was mainly dividend income ¥3.5B and interest income ¥0.3B. Non-operating income was small at 1.3% of Revenue and stable as a recurring source. One-time items included Extraordinary Gain ¥9.2B (primarily gain on sale of investment securities ¥9.2B) and Extraordinary Loss ¥0.6B (loss on disposal of fixed assets ¥0.6B), yielding net extraordinary items of +¥8.6B, approximately 19% of Net Income. The gain on sale of investment securities is non-recurring, but the core driver of profit growth was the operating-level gross margin improvement of +2.4pt, indicating high sustainability of the earnings structure. Comprehensive income ¥72.3B far exceeded Net Income ¥44.3B, with the ¥27.3B difference mainly comprised of valuation differences on securities +¥22.2B and foreign currency translation adjustments +¥4.4B. While valuation gains boost equity, they are sensitive to market fluctuations. With an accrual ratio of -3.6% and OCF exceeding Net Income, earnings quality is high.
Full year guidance forecasts Revenue ¥374.0B (+10.7% YoY), Operating Income ¥57.0B (+6.7%), Ordinary Income ¥60.0B (+7.7%), and Net Income attributable to owners of the parent ¥52.0B. Progress against prior year results is Revenue 90.4%, Operating Income 93.7%, Ordinary Income 92.8%, and Net Income 78.8%, indicating that revenue expansion in the second half is necessary to achieve full-year targets. EPS forecast is ¥239.8 versus prior year actual ¥202.38 (implying +18.5% increase), assuming a return to revenue and profit growth next fiscal year. Dividend forecast is annual ¥52.0 (down from prior year ¥98.0), but prior year may have included special dividends, so this forecast appears to reflect regular dividend policy. Key assumptions to achieve the forecast include demand recovery in the core Functional Products, capacity ramp-up via transfer of Construction in Progress to fixed assets, and improvements in working capital efficiency. Given the current long CCC of 176 days, the need for working capital outlays ahead of revenue growth is a risk factor for plan execution.
Annual dividend was ¥98.0 (Q2-end ¥47.0, year-end ¥51.0), with a payout ratio of 43.0% (based on XBRL data). Against Net Income attributable to owners of the parent ¥41.0B, total dividends amounted to ¥18.5B, implying a payout ratio of approximately 45%, a reasonable level. Free Cash Flow ¥45.9B covered dividends ¥18.5B by 2.48x, and the company conducted share buybacks of ¥20.6B (recorded in Financing Cash Flow). Combined dividend and buybacks totaled ¥39.1B, returning 85% of FCF to shareholders. Total Return Ratio was approximately 95%, an aggressive level, implemented against abundant liquidity with cash and deposits ¥132.0B. Next fiscal year dividend forecast of ¥52.0 is lower than prior year ¥98.0, but prior year may have included special dividends; comparison on a regular dividend basis is required. DOE (dividend on equity) is approximately 3.5%, reflecting a balance between capital efficiency and financial soundness.
Working capital efficiency deterioration risk: With DSO 88 days, DIO 140 days, and CCC 176 days, working capital is elongated and may require front-loaded increases in working capital if sales re-accelerate. Inventory levels ¥34.8B (finished goods ¥34.8B, raw materials ¥29.3B, work-in-progress ¥23.0B) decreased YoY but may still pose a stagnation risk given lower sales. Trade receivables at ¥81.1B remain high; if collection delays or bad debts materialize, OCF could be pressured.
Segment concentration risk: Functional Products account for 78.5% of revenue and 87.8% of operating income, creating concentration risk where demand swings or price competition in that segment materially affect results. Given the sensitivity of cosmetic raw materials and industrial applications to economic cycles, sales and profits could fluctuate significantly in adverse external conditions. Maintaining margin of 17.7% depends on continued product mix improvement and price pass-through; reversal in raw material markets or weakened customer demand would compress margins.
Market price volatility risk of investment securities: Investment securities ¥138.9B (up from ¥108.7B prior year, +27.8%) account for 26.5% of equity, so valuation fluctuations can materially change valuation differences. This period’s valuation gains of +¥22.2B boosted comprehensive income, but market downturns could erode equity via valuation losses, and realizing extraordinary gains through sales would be more difficult. Valuation swings can therefore affect net assets, ROE, and Equity Ratio.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 15.8% | 7.8% (4.6%–12.3%) | +8.1pt |
| Net Profit Margin | 12.1% | 5.2% (2.3%–8.2%) | +6.9pt |
Profitability substantially exceeds the industry median, reflecting a successful strategy of specializing in high value-added products.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | -5.2% | 3.7% (-0.4%–9.3%) | -8.9pt |
Revenue growth rate lags the industry median, affected by demand adjustments in the core segment. Demand recovery and capacity expansion next fiscal year are key to re-accelerating growth.
※ Source: Company aggregation
There is a marked qualitative improvement in the earnings structure, with gross margin 32.9% (up +2.4pt) and operating margin 15.8% (up +2.1pt), forming a three-year trend of increasing margins. A shift to a higher value-added product mix and raw material cost management delivered profit growth despite lower revenue, and this structural change appears sustainable. Next fiscal year guidance anticipates revenue and profit growth, but maintaining margin levels is a prerequisite for achieving targets.
The financial base is extremely robust, with Equity Ratio 80.1%, D/E ratio 0.25x, and cash and deposits ¥132.0B, effectively near net-debt-free. Free Cash Flow ¥45.9B funded dividends ¥18.5B and share buybacks ¥20.6B, enabling aggressive total return of 95% while maintaining net cash. The company has capacity to both prepare for large-scale investments (Construction in Progress ¥33.6B) and continue shareholder returns, balancing growth investment and returns.
Structural issues remain in working capital efficiency (CCC 176 days) and declining Total Asset Turnover (0.52x). In a revenue re-acceleration phase, working capital needs may surge ahead of sales, so improvements in DSO and DIO will be crucial to execution risk. Investment securities ¥138.9B serve as latent assets to cushion the balance sheet but introduce market risk; valuation swings require monitoring due to their potential impact on equity and ROE.
This report is an AI-generated financial analysis document based on XBRL financial statement data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on publicly disclosed financial statements. Investment decisions should be made at your own responsibility and, if necessary, after consulting a professional advisor.